3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
SHENYANG, China, June 28, 2012 /PRNewswire-Asia-FirstCall/ — 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, …